As FDA shortages lift, patients and physicians explore new options for continued treatment with compounded GLP-1 medications.

People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

Zepbound (tirzepatide) is an FDA-approved medication for weight management. People need a prescription to buy this medication, and several telemedicine companies offer doctor-led prescription and ...

Tirzepatide (Mounjaro) has had a remarkable journey to prominence since its UK marketing authorisation in 2023.1 Approved for glycaemic control in type 2 diabetes and weight management in people who ...

72 weeks of treatment with tirzepatide (in association with lifestyle modifications) led to (placebo-subtracted) bodyweight reductions versus baseline values amounting to –16·1% (95% CI −18·7 to −13·5 ...

Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were soaring 15.2% higher as of 11:05 a.m. ET on Wednesday. The big gain came after the small biopharmaceutical company announced its fourth ...

About Zepbound (tirzepatide) injection Zepbound is the first and only ... or overweight and reflects Lilly's current belief and expectations. However, as with any pharmaceutical product, there are ...

The maker of popular Manforce condoms and Prega News pregnancy test kits, Mankind Pharma, is developing ... and Eli Lilly’s tirzepatide (Mounjaro). If successful, Mankind’s drug would be ...